Anti-UCHL1 polyclonal antibody (DPABH-21011)
Goat Anti-Human UCHL1 (aa 211-221) polyclonal antibody for WB
Bring this labeled antibody directly to your bench!
Add to basket
Mouse, Rat, Human
Synthetic peptide: EVRFSAVALCK, corresponding to C terminal amino acids 211-221 of Human PGP9.5
WB: 0.01 - 0.03μg/ml
*Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
UCHL1; ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase); NDGOA; PARK5; PGP95; PGP9.5
Alpha-synuclein signaling; Parkinsons Disease Pathway;
Have you cited DPABH-21011 in a publication? Let us know
and earn a reward for your research.
Liu, Y; Chen, YY; et al. Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson's disease: the impact of ethnicity and onset age. NEUROLOGICAL SCIENCES 36:179-188(2015).
Zhang, MM; Cai, F; et al. Overexpression of ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) delays Alzheimer's progression in vivo. SCIENTIFIC REPORTS 4:-(2014).
Custom Antibody Labeling
We offer labeled antibodies using our catalogue antibody products and a broad range of intensely fluorescent dyes and labels including HRP, biotin, ALP, Alexa Fluor® dyes, DyLight® Fluor dyes, R-phycoerythrin (R-PE), at scales from less than 100 μg up to 1 g of IgG antibody.